Effects of MCI-186 (Edaravone), a Novel Free Radical Scavenger, Upon Experimental Atherosclerosis in Apolipoprotein E-Deficient Mice

  • Okabe Taka-aki
    Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Kishimoto Chiharu
    Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Shimada Kana
    Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Murayama Toshinori
    Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Yokode Masayuki
    Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University
  • Kita Toru
    Department of Cardiovascular Medicine, Graduate School of Medicine, Kyoto University

この論文をさがす

抄録

Background Recent evidence suggests that oxidative stress may play a role in the development of atherosclerosis. MCI-186 (3-methyl-1-phenyl-1-parazolin-5-one, edaravone) is a novel free radical scavenger, but it remains unclear whether free radical scavengers would be effective for the prevention of the disease. Methods and Results Experimental atherosclerosis was induced in apolipoprotein E-deficient mice fed a high-fat diet containing 0.3% cholesterol. Mice were treated with an intraperitoneal injection of either MCI-186 1 mg/kg per day or MCI-186 10 mg/kg per day on alternate days over 4 weeks. Fatty streak lesion was suppressed by MCI-186 10 mg/kg per day administration, but not by mg/kg per day. Immunohistochemical analysis showed that macrophage and CD4+ T-cell accumulation and oxidative stress overload in the fatty streak lesion were suppressed in mice that received MCI-186 treatment. Conclusions MCI-186 administration suppressed the development of atherosclerosis, associated with reduced expression of both immune-activated cells and oxidative stress in fatty streak plaques. (Circ J 2006; 70: 1216 - 1219)<br>

収録刊行物

  • Circulation Journal

    Circulation Journal 70 (9), 1216-1219, 2006

    一般社団法人 日本循環器学会

被引用文献 (7)*注記

もっと見る

参考文献 (34)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ